Codeine is an opioid pain medication used to treat mild to moderate pain. The market for codeine is influenced by various factors such as increasing cases of pain-related disorders, the rising geriatric population, and the high prevalence of chronic diseases. However, the market growth is restricted due to various side effects associated with codeine, including addiction and overdose, which have led to government regulations. The market for codeine is also affected by the availability of alternative pain management therapies and the emergence of new drugs with improved safety profiles. The North American region dominates the global codeine market due to the high prevalence of pain disorders and the availability of advanced healthcare facilities. The market is expected to grow at a moderate pace in the coming years.
Major Players in the Codeine Industry:
1. Nexgen Pharma, Inc.
Nexgen Pharma, Inc. is a privately held pharmaceutical company founded in 2003, with its headquarters in Irvine, California. The company specializes in developing and manufacturing solid dose and powder pharmaceutical products, as well as providing contract development and manufacturing services. In 2020, Nexgen Pharma, Inc. announced the launch of its generic version of potassium chloride extended-release tablets.
2. Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company founded in 1901, with its headquarters in Petah Tikva, Israel. The company operates in more than 60 countries and specializes in developing, manufacturing, and marketing generic and branded pharmaceuticals, as well as active pharmaceutical ingredients. In 2021, Teva announced the launch of its generic version of NuvaRing, a contraceptive vaginal ring.
3. Wraser Pharmaceuticals LLC
Wraser Pharmaceuticals LLC is a privately held pharmaceutical company founded in 2018, with its headquarters in Boston, Massachusetts. The company focuses on developing and commercializing innovative drugs in the oncology space. In 2020, Wraser Pharmaceuticals announced the completion of a $36.5 million Series A financing round to support the development of its lead compound, WRA-001.
4. Larken Laboratories, Inc.
Larken Laboratories, Inc. is a privately held pharmaceutical company founded in 2013, with its headquarters in Walnut Creek, California. The company specializes in developing and commercializing dermatological products for the treatment of a range of skin conditions. In 2020, Larken Laboratories announced the launch of its generic version of Fluorouracil Cream.
5. Aurobindo Pharma Limited
Aurobindo Pharma Limited is a global pharmaceutical company founded in 1986, with its headquarters in Hyderabad, India. The company operates in over 150 countries and specializes in developing and manufacturing generic and branded pharmaceuticals, as well as active pharmaceutical ingredients. In 2020, Aurobindo Pharma announced the launch of its generic version of Tamiflu, an antiviral medication used to treat influenza.
6. Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited is a global pharmaceutical company founded in 1983, with its headquarters in Mumbai, India. The company operates in over 100 countries and specializes in developing, manufacturing, and marketing generic and branded pharmaceuticals, as well as active pharmaceutical ingredients. In 2021, Sun Pharma announced the launch of its generic version of Absorica, a medication used to treat severe acne.
7. Tris Pharma Inc.
Tris Pharma Inc. is a privately held pharmaceutical company founded in 2000, with its headquarters in Monmouth Junction, New Jersey. The company specializes in developing and commercializing extended-release drug delivery technologies. In 2020, Tris Pharma announced the launch of its generic version of Focalin XR, a medication used to treat attention-deficit/hyperactivity disorder.
8. Johnson & Johnson
Johnson & Johnson is a global healthcare company founded in 1886, with its headquarters in New Brunswick, New Jersey. The company operates in over 60 countries and specializes in developing, manufacturing, and marketing pharmaceuticals, medical devices, and consumer health products. In 2021, Johnson & Johnson announced the FDA approval of its COVID-19 vaccine, developed by its subsidiary Janssen Pharmaceuticals.
*Definition- Codeine is an opioid pain medication used to treat mild to moderate pain. It works by binding to specific receptors in the brain and blocking the transmission of pain signals.
